Knocking down galectin 1 in human Hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses

Journal of Neuropathology and Experimental Neurology

Volumn 67, Issue 5, 2008, Pages 456-469

  Mercier, Marie Le ^a   Mathieu, Véronique ^a   Haibe Kains, Benjamin ^a,b   Bontempi, Gianluca ^a   Mijatovic, Tatjana ^a   Decaestecker, Christine ^a   Kiss, Robert ^a,d   Lefranc, Florence ^a,c  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b JULES BORDET INSTITUTE   (Belgium)

^c ERASME HOSPITAL   (Belgium)

^d FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Angiogenesis; Endoplasmic reticulum stress; Galectin 1; Glioblastoma; Hypoxia

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CELL ENZYME; CYSTEINE RICH PROTEIN 61; GALECTIN 1; OXYGEN REGULATED PROTEIN 150; RIBONUCLEASE INOSITOL REQUIRING 1 ALPHA; SMALL INTERFERING RNA; TEMOZOLOMIDE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOUSE; NEUROMODULATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; NUDE MOUSE; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CELL LINE, TUMOR; DACARBAZINE; DOWN-REGULATION; ENDOPLASMIC RETICULUM; ENDORIBONUCLEASES; FEMALE; GALECTIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENE THERAPY; GLIOBLASTOMA; HSP40 HEAT-SHOCK PROTEINS; HUMANS; MEMBRANE PROTEINS; MICE; MOLECULAR CHAPERONES; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 43249107550     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e318170f892     Document Type: Article

References (67)

1. Lefranc F, Brotchi J, Kiss R. Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 2005;23:2411-22.
2. Lefranc F, Sadeghi N, Camby I, et al. Present and potential future issues in glioblastoma treatment. Expert Rev Anticancer Ther 2006;6:719-32
3. Rong Y, Durden DL, Van Meir EG, et al. 'Pseudopalisading' necrosis in glioblastoma: A familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 2006;65:529-39
4. Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nat Rev Cancer 2005;5:29-41
5. Camby I, Le Mercier M, Lefranc F, et al. Galectin-1: A small protein with major functions. Glycobiology 2006;16:137R-57R
6. Camby I, Belot N, Lefranc F, et al. Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol 2002;61:585-96
7. Camby I, Belot N, Rorive S, et al. Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol 2001;11:12-26
8. Baum LG, Seilhamer JJ, Pang M, et al. Synthesis of an endogeneous lectin, galectin-1, by human endothelial cells is up-regulated by endothelial cell activation. Glycoconj J 1995;12:63-68
9. Thijssen VL, Postel R, Brandwijk RJ, et al. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci U S A 2006;103:15975-80
10. Thijssen VL, Poirier F, Baum LG, et al. Galectins in the tumor endothelium: Opportunities for combined cancer therapy. Blood 2007;110:2819-27
11. Perillo NL, Pace KE, Seilhamer JJ, et al. Apoptosis of T cells mediated by galectin-1. Nature 1995;378:736-39
12. Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 2007;25:267-96
13. Le QT, Shi G, Cao H, et al. Galectin-1: A link between tumor hypoxia and tumor immune privilege. J Clin Oncol 2005;23:8932-41
14. Keith B, Simon MC. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007;129:465-72
15. Kim JW, Gao P, Dang CV. Effects of hypoxia on tumor metabolism. Cancer Metastasis Rev 2007;26:291-98
16. Magagnin MG, Koritzinsky M, Wouters BG. Patterns of tumor oxygenation and their influence on the cellular hypoxic response and hypoxia-directed therapies. Drug Resist Updat 2006;9:185-97
17. van den Beucken T, Koritzinsky M, Wouters BG. Translational control of gene expression during hypoxia. Cancer Biol Ther 2006;5:749-55
18. Koumenis C. ER stress, hypoxia tolerance and tumor progression. Curr Mol Med 2006;6:55-69
19. Pouyssegur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006;441:437-43
20. Branle F, Lefranc F, Camby I, et al. Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy. Cancer 2002;95:641-55
21. Mathieu V, Le Mercier M, De Neve N, et al. Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model. J Invest Dermatol 2007;127:2399-2410
22. Lefranc F, Sadeghi N, Metens T, Brotchi J, Salmon I, Kiss R. Characterization of gastrin-induced cytostatic effect on cell proliferation in experimental gliomas. Neurosurgery 2003;52:881-90
23. Thakker DR, Natt F, Husken D, et al. Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference. Proc Natl Acad Sci U S A 2004;101:17270-75
24. Development Core Team. 2006. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
25. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80
26. Wilson CL, Miller CJ. Simpleaffy: A BioConductor package for Affymetrix Quality Control and data analysis. Bioinformatics 2005;21:3683-85
27. Bolstad BM, Irizarry RA, Astrand M, et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185-93
28. Hosack DA, Dennis G Jr, Sherman BT, et al. Identifying biological themes within lists of genes with EASE. Genome Biol 2003;4:R70
29. Hendrix MJ, Seftor EA, Hess AR, et al. Vasculogenic mimicry and tumour-cell plasticity: Lessons from melanoma. Nat Rev Cancer 2003;3:411-21
30. Yue WY, Chen ZP. Does vasculogenic mimicry exist in astrocytoma? J Histochem Cytochem 2005;53:997-1002
31. Sun B, Zhang D, Zhang S, et al. Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer Lett 2007;249:188-97
32. Ozawa K, Tsukamoto Y, Hori O, et al. Regulation of tumor angiogenesis by oxygen-regulated protein 150, an inducible endoplasmic reticulum chaperone. Cancer Res 2001;61:4206-13
33. Kuwabara K, Matsumoto M, Ikeda J, et al. Purification and characterization of a novel stress protein, the 150-kDa oxygen-regulated protein (ORP150), from cultured rat astrocytes and its expression in ischemic mouse brain. J Biol Chem 1996;271:5025-32
34. Ozawa K, Kondo T, Hori O, et al. Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport. J Clin Invest 2001;108:41-50
35. Berger BJ, Muller TS, Buschmann IR, et al. High levels of the molecular chaperone Mdg1/ERdj4 reflect the activation state of endothelial cells. Exp Cell Res 2003;290:82-92
36. Prols F, Mayer MP, Renner O, et al. Upregulation of the cochaperone Mdg1 in endothelial cells is induced by stress and during in vitro angiogenesis. Exp Cell Res 2001;269:42-53
37. Spector DL. Nuclear domains. J Cell Sci 2001;114:2891-93
38. Yamamoto K, Yoshida H, Kokame K, Kaufman RJ et al. Differential contributions of ATF6 and XBP1 to the activation of endoplasmic reticulum stress-responsive cis-acting elements ERSE, UPRE and ERSE-II. J Biochem 2004;136:343-50
39. Yoshida H, Haze K, Yanagi H, et al. Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors. J Biol Chem 1998;273:33741-49
40. Yoshida H, Okada T, Haze K, et al. ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Mol Cell Biol 2000;20:6755-67
41. Kokame K, Kato H, Miyata T. Identification of ERSE-II, a new cis-acting element responsible for the ATF6-dependent mammalian unfolded protein response. J Biol Chem 2001;276:9199-9205
42. Wang Y, Shen J, Arenzana N, et al. Activation of ATF6 and an ATF6 DNA binding site by the endoplasmic reticulum stress response. J Biol Chem 2000;275:207013-20
43. Mizobuchi N, Hoseki J, Kubota H, et al. ARMET is a soluble ER protein induced by the unfolded protein response via ERSE-II element. Cell Struct Funct 2007;23:41-50
44. Wolfgang CD, Chen BPC, Martindale JL, et al. Gadd153/Chop10, a potential target gene of the transcriptional repressor ATF3. Mol Cell Biol 1997;17:6700-6707
45. Kaneda S, Yura T, Yanagi H. Production of three distinct mRNAs of 150 kDa oxygen-related protein (ORP150) by alternative promoters: Preferential induction of one species under stress conditions. J Biochem 2000;128:529-38
46. Shimo T, Kubota S, Kondo S, et al. Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line. Cancer Lett 2001;174:57-64
47. Ameri K, Hammond EM, Culmsee C, et al. Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signaling pathway. Oncogene 2007;26:284-89
48. Blais JD, Filipenko V, Bi M, et al. Activating transcription factor 4 is translationally regulated by hypoxic stress. Mol Cell Biol 2004;24:7469-82
49. Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: Coordination of gene transcriptional and translational controls. Genes Dev 1999;13:1211-33
50. Hori O, Matsumoto M, Kuwabara K, et al. Exposure of astrocytes to hypoxia/reoxygenation enhances expression of glucose-regulated protein 78 facilitating astrocyte release of the neuroprotective cytokine interleukin 6. J Neurochem 1996;66:973-79
51. Paris S, Denis H, Delaive E, et al. Up-regulation of 94-kDa glucose-regulated protein by hypoxia-inducible factor-1 in human endothelial cells in response to hypoxia. FEBS Lett 2005;579:105-14
52. Babic AM, Kireeva ML, Kolesnikova TV, et al. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci U S A 1998;95:6355-60
53. Kunz M, Moeller S, Koczan D, et al. Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells. J Biol Chem 2003;278:45651-60
54. Zhang K, Kaufman RJ. The unfolded protein response: A stress signaling pathway critical for health and disease. Neurology 2006;66:S102-9
55. Zhao L, Ackerman SL. Endoplasmic reticulum stress in health and disease. Curr Opin Cell Biol 2006;18:444-52
56. Ozawa K, Kuwabara K, Tamatani M, et al. 150-kDa oxygen-regulated protein (ORP150) suppresses hypoxia-induced apoptotic cell death. J Biol Chem 1999;274:6397-6404
57. Pelham HR. Speculations on the functions of the major heat shock and glucose-regulated proteins. Cell 1986;46:959-61
58. Tamatani M, Matsuyama T, Yamaguchi A, et al. ORP150 protects against hypoxia/ischemia-induced neuronal death. Nat Med 2001;7:317-23
59. Kitano H, Nishimura H, Tachibana H, et al. ORP150 ameliorates ischemia/reperfusion injury from middle cerebral artery occlusion in mouse brain. Brain Res 2004;1015:122-28
60. Bando Y, Tsukamoto Y, Katayama T, et al. ORP150/HSP12A protects renal tubular epithelium from ischemia-induced cell death. FASEB J 2004;18:1401-3
61. Nozaki J, Kubota H, Yoshida H, et al. The endoplasmic reticulum stress response is stimulated through the continuous activation of transcription factors ATF6 and XBP1 in Ins2+/Akita pancreatic beta cells. Genes Cells 2004;9:261-70
62. Iwawaki T, Hosoda A, Okuda T, et al. Translational control by the ER transmembrane kinase/ribonuclease IRE1 under ER stress. Nat Cell Biol 2001;3:158-64
63. Park JW, Voss PG, Grabski S, et al. Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein. Nucleic Acids Res 2001;29:3595-3602
64. Patterson RJ, Wang W, Wang JL. Understanding the biochemical activities of galectin-1 and galectin-3 in the nucleus. Glycoconj J 2004;19:499-506
65. Wang W, Park JW, Wang JL, et al. Immunoprecipitation of spliceosomal RNAs by antisera to galectin-1 and galectin-3. Nucleic Acids Res 2006;34:5166-74
66. Ingrassia L, Camby I, Lefranc F, et al. Anti-galectin compounds as potential anti-cancer drugs. Curr Med Chem 2006;13:3513-27
67. Rabinovich GA, Cumashi A, Bianco GA, et al. Synthetic lactulose amines: Novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis. Glycobiology 2006;16:210-20